Home About us Team Portfolio Press Contact Careers

News

April 18th 2012
MerLion Announces Initiation of a Phase III Clinical Programme to Evaluate Finafloxacin for the Treatment of Acute Otitis Media


February 13th 2012
HeidelbergCapital sells its Shares in Framas Kunststofftechnik GmbH


January 19th 2012
4SC AG: Cancer compound resminostat meets primary endpoint in Phase II trial in advanced liver cancer ahead of schedule


HeidelbergCapital is an independent Private Equity Funds Group, specialising in Secondary Direct Investments, e.g. the acquisition of shareholdings in companies previously held by private equity/venture capital funds or banks.
Deutsch Imprint Print view / Druckansicht
Log in